Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Peptide 144 TGF- β1 inhibitor (TSLDASIIWAMMQN)

EU orphan designation number: EU/3/05/326   
Active ingredient: Peptide 144 TGF- β1 inhibitor (TSLDASIIWAMMQN)
Indication: Treatment of systemic sclerosis
Sponsor: Digna Biotech S.L.
Avenida Pio XII, 22, oficina 2, 31008 Pamplona, Navarra, España

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/11/2005 Orphan designation EMEA/OD/035/05 (2005)4354 of 28/10/2005
22/06/2010 Change of name and/or address of sponsor EMEA/OD/035/05